When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Кольцевидная гранулема

Evidence last reviewed: 30 Mar 2026
Topic last updated: 26 Nov 2020

Summary

Definition

History and exam

Key diagnostic factors

  • бессимптомные сгруппированные аннулярные дермальные папулы розового или телесного цвета
Full details

Other diagnostic factors

  • телесного цвета, розовый или коричневый macules или небольшие папулы
  • узлы в мягких тканях
  • перфорирующие папулы, корочки или язвенные поражения
  • эритематозные пятна
Full details

Risk factors

  • сахарный диабет
  • Злокачественное заболевание крови
  • опоясывающий лишай
  • ВИЧ
  • гепатит
  • гиперлипидемия
  • заболевания щитовидной железы
  • лекарственные препараты
Full details

Diagnostic investigations

1st investigations to order

  • клинический диагноз
Full details

Investigations to consider

  • биопсия кожи
  • уровень сахара в крови натощак
  • исследование функции щитовидной железы
  • скрининг липидов
  • скрининг гепатита
  • исследование на ВИЧ
Full details

Treatment algorithm

ACUTE

локализованная форма (классическая кольцевая сыпь)

генерализованная форма (распространенная макулярная сыпь)

перфорирующая форма (корочки или язвенные поражения)

подкожная форма (мягкий узелок)

пятнистая форма (эритематозные бляшки)

Contributors

Authors

Misha Rosenbach, MD

Associate Professor

Dermatology and Internal Medicine

University of Pennsylvania

Philadelphia

PA

Declarações

MR has received consulting fees from Merck, aTyr Pharma, and Processa Pharma, not related to granuloma annulare. He has received grant support from Processa Pharma, not related to granuloma annulare. MR has received salary support from the AMA/JAMA for his role at JAMA Dermatology as Deputy Editor. MR is an author of references cited in this topic.

Agradecimentos

Dr Misha Rosenbach would like to gratefully acknowledge Dr Susmita Mukherjee, a previous contributor to this topic. SM declares that she has no competing interests.

Revisores

Aisha Sethi, MD

Assistant Professor of Medicine

Associate Residency Program Director

University of Chicago

Chicago

IL

Declarações

AS declares that she has no competing interests.

Robert Herd, MSc, MD, FRCP

Consultant Dermatologist

Department of Dermatology

Nuffield Hospital

Glasgow

UK

Declarações

RH declares that he has no competing interests.

Brenda L. Pellicane, MD

Dermatologist

Wayne State University School of Medicine

Department of Dermatology

Detroit

MI

Declarações

BLP declares that she has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Piette EW, Rosenbach M. Granuloma annulare: clinical and histologic variants, epidemiology, and genetics. J Am Acad Dermatol. 2016 Sep;75(3):457-65. Resumo

Thornsberry LA, English JC 3rd. Etiology, diagnosis, and therapeutic management of granuloma annulare: an update. Am J Clin Dermatol. 2013 Aug;14(4):279-90. Resumo

Piette EW, Rosenbach M. Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options. J Am Acad Dermatol. 2016 Sep;75(3):467-79. Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

O uso deste conteúdo está sujeito ao nosso aviso legal